Posted by AGORACOM-JC
at 11:19 AM on Monday, August 17th, 2020
Announced that its common shares are now trading on the OTCQB Venture Market under the stock symbol “IDKFF”
OTCQB Venture is the premiere marketplace for early stage and developing U.S. and international companies.
Sheldon Inwentash, Chairman and CEO, stated, “The commencement of trading on the OTCQB is an important milestone because it provides the massive audience of American small cap investors an ability to easily invest in ThreeD Capital and participate in our growth…”
TORONTO, Aug. 17, 2020 — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQB:IDKFF), a Canadian based venture capital firm that invests in disruptive companies and promising junior resources companies, is pleased to announce that its common shares are now trading on the OTCQB Venture Market (“OTCQB Venture”) under the stock symbol “IDKFF”.
The OTCQB Venture is the premiere marketplace for early stage and developing U.S. and international companies. Participating companies must be current in their reporting and undergo an annual verification and management certification process. Investors can find real-time quote and market information at https://www.otcmarkets.com/stock/IDKFF/overview.
The Company believes that the OTCQB Venture Market can provide efficient market access to U.S. investors, helping Canadian companies with U.S. investors build shareholder value through greater access to enhanced liquidity and data distribution. ThreeD’s common shares will continue to trade on the Canadian Securities Exchange (“CSE”) under the symbol “IDK”.
Sheldon Inwentash, Chairman and CEO, stated, “The commencement of trading on the OTCQB is an important milestone because it provides the massive audience of American small cap investors an ability to easily invest in ThreeD Capital and participate in our growth. We have received significant interest from American investors in the past who want the exposure ThreeD Capital can provide them to ground floor opportunities in both small cap stocks at early stages, or private disruptive technologies, making this listing valuable to our corporate objectives.”
NEW THREED CAPITAL WEBSITE DISCLOSES ADDITIONAL INFORMATION REGARDING SECTOR INVESTMENTS
The Company also wishes to advise the launch of its updated website at https://threedcapital.com/ which, amongst other things, provides investors with additional insight into the Company’s holdings in both the technology and resources sector.
As of this date, ThreeD Capital now holds investments in 22 technology companies and 12 mining companies.
This press release is available on the Company’s Verified Investor Discussion Forum on AGORACOM for constructive discussion and engagement with shareholders https://agoracom.com/ir/threedcapital
About ThreeD Capital Inc.
ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the Junior Resources, Artificial Intelligence and Blockchain sectors. ThreeD seeks to invest in early stage, promising companies and ICOs where it may be the lead investor and can additionally provide investees with advisory services, mentoring and access to the Company’s ecosystem.
For further information: Gerry Feldman, CPA, CA Chief Financial Officer and Corporate Secretary [email protected] Phone: 416-941-8900 ext 106
Forward-Looking Statements
This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as “forward-looking statements”) within the meaning of Canadian securities laws. All statements other than statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the future events or circumstances contemplated by the forward-looking statements will not occur. Although the Company believes that the expectations reflected in the forward looking statements contained in this press release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause the Company’s actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.
Posted by AGORACOM-JC
at 8:08 AM on Monday, August 17th, 2020
Company’s online betting platform, VIE.gg, became an official multi-year partner of Dignitas in June 2019, and under the expanded partnership, it has now secured the naming rights of Dignitas’ famed CS:GO team
CS:GO Team Will Compete as Dignitas VIE.gg in Official Events
Partnership Activations to Utilize Dignitas’ New Jersey Based Gaming Facility
BIRKIRKARA, Malta, Aug. 17, 2020 — Esports Entertainment Group, Inc. (NasdaqCM: GMBL, GMBLW) ( the “Company”), a licensed online gambling company with a focus on esports wagering and 18+ gaming, is pleased to announce an expanded partnership with Dignitas, the esports vertical of New Meta Entertainment Inc. (NME) and one of the most successful esports organizations in the world. The Company’s online betting platform, VIE.gg, became an official multi-year partner of Dignitas in June 2019, and under the expanded partnership, it has now secured the naming rights of Dignitas’ famed CS:GO team.
“Dignitas is a true leader in the esports community,” said Grant Johnson, CEO. “Expanding our existing partnership and placing our brand in front of the millions of engaged Dignitas fans around the world further demonstrates our commitment to growing VIE.gg into the leading wagering platform in esports globally.”
In addition to VIE.gg’s integration into the CS:GO naming rights and jersey, the partners will roll out strategic digital and physical activations with the New Jersey marketplace as a core focus. In June 2018, New Jersey Governor Phil Murphy signed Assembly Bill 411, legalizing sports betting in New Jersey. One year later, Dignitas became the first esports organization to open a gaming facility in Newark, New Jersey, next to the famed sports and entertainment facility, Prudential Center. In addition to U.S. sports betting, the partnership also paves the way into the European marketplace through association with Dignitas’ famed CS:GO team hailing from Scandinavia.
“The partnership’s focus on digital and physical activations in the New Jersey market is ideally timed for us as we move forward on our application for our New Jersey gaming license,” continued Johnson.
Esports Entertainment Group, a member of ESIC, is working together with NME, to ensure that conflicts of interest and betting and age requirement rules are upheld throughout.
“We are honored to partner with an innovative, multinational brand like VIE.gg,” said Michael Prindiville, CEO of New Meta Entertainment and Dignitas. “Our co-branded CS:GO team and the immense opportunity around esports betting content in our home state of New Jersey enable us to tell unique and engaging stories at the forefront of both esports betting and competition to millions of fans worldwide.”
“We are excited to further expand our partnership with Dignitas,” commented Magnus Leppäniemi, VP of Marketing and Head of Esports at Esports Entertainment Group. “As a committed long-term partner, we’re thrilled to have the opportunity to co-brand our VIE.gg platform alongside Dignitas’ legendary CS:GO team, an opportunity that can introduce our brand to millions of esports fans globally and help establish our status as a Tier 1 operator within esports betting.”
ABOUT DIGNITAS:
Since its formation in 2003, Dignitas has established itself as one of the most successful esports organizations in the world, amassing 18 World Championships across multiple game titles. In September 2016, Dignitas was acquired by the NBA’s Philadelphia 76ers of Harris Blitzer Sports & Entertainment (HBSE), a diverse, global portfolio of sports and entertainment franchises and properties that includes the Philadelphia 76ers (NBA), New Jersey Devils (NHL) and more. In June 2019, Dignitas merged with Fertitta Entertainment’s League of Legends LCS franchise, Clutch Gaming, and through investment with Susquehanna International Group and Delaware North, formed the parent company New Meta entertainment, Inc. (NME), to expand the esports business into a broader digital sports and entertainment company. Dignitas currently fields seven teams in five of esports’ largest and most popular games: League of Legends, Counter-Strike: Global Offensive (men’s and women’s teams), Super Smash Bros., Rocket League, and Clash Royale – as well as a host of digital influencers. With player content studios and wellness facilities in Newark, NJ and Los Angeles, and infrastructure in Europe and China, Dignitas is the global leader dedicated to esports athletes and gaming entertainers.
ABOUT ESPORTS ENTERTAINMENT GROUP
Esports Entertainment Group, Inc. is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. The Company holds a license to conduct online gambling and 18+ gaming on a global basis in Malta and Curacao, Kingdom of the Netherlands and is able to accept wagers from over 149 jurisdictions including Canada, Japan, Germany and South Africa. Esports Entertainment offers fantasy, pools, fixed odds and exchange style wagering on esports events in a licensed, regulated and secure platform to the global esports audience at vie.gg. In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multi-player mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company maintains offices in Malta. For more information visit www.esportsentertainmentgroup.com
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.
Contact:
U.S. Investor Relations RedChip Companies, Inc. Dave Gentry 407-491-4498 [email protected]
Posted by AGORACOM-JC
at 7:36 AM on Monday, August 17th, 2020
Successfully launched advanced “medical cannabis 2.0” products under RHO Phyto™ brand nation-wide in Canada through Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart
Revenue increase of 172% from $260,903 in Q1 2020 to $709,468 in Q2 2020, and a substantial increase from $16,571 in Q2 2019, coupled with 8% cost reduction from Q1 2020, and 31% cost reduction from Q2 2019
Continued to fortify cannabinoid research and clinical leadership position in Canada with advancements with several collaborations with world class institutions including the MC-RWE by UHN
TORONTO, Aug. 17, 2020 – Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products announces results for the three and six months ended June 30, 2020.
Aras Azadian, Chief Executive Officer of Avicanna, commented “We continued to make strategic, scientific and commercial progress during the quarter while optimizing our global operations, which is demonstrated through quarter to quarter revenue increases and cost reductions. We are at an inflection point where our differentiated and advanced product lines are commencing sales in major markets and we are demonstrating evidence of our diversified business model which is comprised of seeds, API, advanced finished products, and royalties from intellectual property. Furthermore, we continue to fortify our thought leadership position within the medical community in Canada with various world class research collaborations, which now include the strategically significant real-world evidence trials on our RHO Phyto products available in the Canadian market.”
First Quarter Financial and Operational Highlights
The Company continued to make strides in its strategic commercial initiatives, leading to an increase in revenues of 172% from $260,903 in the first quarter of 2020 to $709,468 in the second quarter of 2020, and an increase of 4,181% from $16,571 in the second quarter of 2019. In addition, the Company was able to reduce general and administrative costs by approximately 8% from $3,185,943 in the first quarter of 2020 to $2,924,462 in the second quarter of 2020 and a decrease of 31% from $4,243,276 in the second quarter of 2019. The Company has approximately $3.9M of inventory available for sale.
Three Month
Q2 2020
Q1 2020
Q2 2019
Revenue
$709,486
$260,903
$16,571
G&A
$2,924,462
$3,185,943
$4,243,276
The Company announced the co-development of a cannabinoid-based product for treatment of COVID-19 related lung inflammation in partnership with the University of Toronto, with additional support and funding from the Mitacs Accelerate Program grant (the “Mitacs Grant“). Dr. Christine Allen is a global leader in the research and development of pharmaceutical formulations and for the past three years, Avicanna and Dr. Christine Allen’s research group (“CARG“) have developed novel cannabinoid-based products for commercialization. The combined expertise of Avicanna and CARG will fast-track the development of advanced pharmaceutical formulations of cannabinoids and their route to market.
The Company announced the successful registration of the Company’s initial line of products for its CBD-based derma-cosmetic product line, Pura H&W, in the European Union. The Company is anticipating the commercial launch of its Pura H&W line in the United Kingdom in the third quarter of 2020. Avicanna successfully met all regulatory requirements of the European Commission’s Cosmetic Product Notification Portal (the “CPNP“). In addition to the clinical studies conducted on two of the registered products, Avicanna has provided the CPNP with long-term stability studies on these initial SKUs along with primary skin irritation evaluations for the entire portfolio in order to certify the safety and stability of the Pura H&W formulations.
Through its genetics and seed division, Avesta Genetica, Avicanna completed its first industrial-scale seed harvest in Colombia. Approximately 80 million premium and feminized cannabigerol (“CBG“) dominant seeds were successfully harvested. The seeds have been tested for germination and attained feminization rates of 99%, which are considered premium within the global seed market. The seeds will be utilized for sales, exports, and local production. Additionally, the Company’s first ever export of hemp seeds (genetics) was approved by the Colombian government, which was also the first export of cannabis or hemp seeds in Colombian history.
The Company entered a strategic manufacturing and intellectual property (“IP“) licensing agreement with MediPharm Labs Inc. (“MediPharm“). Under the terms of the agreement, MediPharm will use its manufacturing capabilities under its Good Manufacturing Practice (“GMP“) certification in Canada to produce Avicanna’s advanced RHO Phyto medical cannabis products, and Pura H&W topicals for sale by Medical Cannabis by Shoppers. The partnership provides Avicanna with a route to market for Canadian and international sales, as well as pharmaceutical manufacturing for clinical trials with its Canadian research hospital collaborators. Additionally, Avicanna will grant MediPharm a license to use proprietary Avicanna formulations to develop additional white label branded products for the domestic and international market. MediPharm’s pharmaceutical and GMP-certified manufacturing capabilities and its international supply chain capabilities will be leveraged to produce and deliver the proprietary finished products to partners worldwide.
At the height of the COVID-19 pandemic, the Company closed a non-brokered private placement for approximately $2.56 million, issuing 3,200,000 units at a price of $0.80 per unit. The financing primarily included strategic partners, including Tasly International Capital Limited, a division of Tasly Holding Group Co., Ltd., a large healthcare and pharmaceutical group in China.
The Company reduced its operating cash outflows by approximately 40%, for the six months ending June 30, 2020, compared to the six months ending June 30, 2019.
Recent Developments
The Company’s RHO Phyto medical cannabis products launched on the Medical Cannabis by Shoppers portal, commencing with the “Micro Drop” oil formulations. Micro Drop oil formulations are the first of the RHO Phyto formulary of advanced medical cannabis products available for patients and health care practitioners on the Medical Cannabis by Shoppers platform. This product line includes advanced formulations under the “Cannabis 2.0” regulations that have undergone years of research and development and been manufactured under GMP standards by MediPharm. RHO Phyto sublingual sprays and topical products are expected to be available through the Medical Cannabis by Shoppers platform in the third quarter of 2020, with capsules to follow in the fourth quarter. Medical Cannabis by Shoppers is a subsidiary of Shoppers Drug Mart Inc.
On August 11, 2020, the Company announced a strategic partnership with Red White & Bloom Brands Inc. (“RWB”), a multi-state operator active in the U.S. cannabis and hemp sectors, for the distribution of and commercialization of Pura H&W Hemp-Derived CBD-Based Topical Products in the United States. RWB will pay Avicanna an upfront fee in the amount of CAD$250,000 in cash, along with minimum purchase requirements, including the purchase of USD$250,000 worth of product within the first six months of the term, for the rights to be the exclusive distributor of Avicanna’s Pura H&W branded cosmetic products in the US. Under the agreement, RWB also has the right to purchase Avicanna’s cosmetic products for distribution into the US and certain other territories under brands of RWB’s choosing. The initial product offerings under the agreement will include body and face lotions, cosmetic creams, gels and serums, as well as soaps and bath bombs.
Avicanna, in collaboration with CARG at the Leslie Dan Faculty of Pharmacy at the University of Toronto, was awarded additional non-dilutive funding in the form of a peer-reviewed grant by the Natural Sciences and Engineering Research Council of Canada (“NSERC“) to develop a cannabinoid-based formulation for the treatment of COVID-19 related lung inflammation. This peer reviewed grant provides funding support in addition to the recently awarded Mitacs Grant.
In collaboration with Dr. Jibran Khokhar, an Assistant Professor at the University of Guelph, Avicanna was also awarded a two-year NSERC Alliance grant to evaluate the neurobiological underpinnings of cannabis toxicosis in a preclinical model, and to test the potential efficacy of Avicanna’s naturally-derived cannabinoids and formulations for treatment of tetrahydrocannabinol (“THC“) overdose.
In anticipation of the launch of the RHO Phyto product line in Canada, Avicanna hosted its third annual symposium, “Medical Cannabis 2.0”, on July 21st, 2020 through a virtual format. The presentations focused on the evolution of medical cannabis including the Avicanna led advancements in R&D for novel cannabinoid delivery forms and formulations. Presenters including Dr. Ruth Ross (Professor and Chair, Department of Pharmacology & Toxicology, Faculty of Medicine, University of Toronto, Senior Scientist, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health) and Dr. Hance Clarke (Staff Anesthesiologist, Director Pain Services, Director Good Hope Ehlers Danlos Clinic, Medical Director of The Pain Research Unit, Department of Anesthesia and Pain Management, Toronto General Hospital, University Health Network, Associate Professor, Department of Anesthesia, University of Toronto). Over 1,000 participants attended the symposium.
Avicanna announced that its RHO Phyto line of products will be participating in a Medical Cannabis Real-World Evidence (“MC-RWE“) clinical study at the University Health Network (“UHN“) in partnership with Medical Cannabis by Shoppers. The study will be led by Dr. Hance Clarke, Director of Pain Services at Toronto General Hospital, and will examine the efficacy of a select group of medical cannabis products including Avicanna’s RHO Phyto line of products on patient reported outcomes of pain, sleep and anxiety. All products used in MC-RWE must complete analytical testing through select testing laboratories and entered through the TruTrace StrainSecure™ platform. This provides Avicanna with a second commercial channel to the Medical Cannabis by Shoppers portal for its medical products to UHN, which is Canada’s largest network of research hospitals and doctors.
Summary of Operations ($CDN)
Three Months Ended
Six Months Ended
June 30, 2020
June 30, 2019
June 30, 2020
June 30, 2019
$
$
$
$
Revenues
709,468
16,571
970,371
40,594
Inventory Production Costs expensed to Cost of Sales
(133,481)
–
(234,288)
–
Fair value changes in biological assets included in inventory sold
(540,884)
–
(569,552)
–
Unrealized gain on changes in fair value of biological assets
(88,849)
–
1,827,271
–
General and administrative
2,924,462
4,243,276
6,110,405
6,930,482
Share-based compensation
1,277,770
674,929
1,615,962
1,719,568
Depreciation and amortization
330,685
128,822
839,828
185,117
Impairment of goodwill
686,845
–
686,845
–
Total Expenses
(5,219,762)
(5,047,027)
(9,253,040)
(8,835,167)
Other income (loss)
(2,372,674)
522,257
(2,496,480)
400,898
Net loss before taxes
(7,646,182)
(4,508,199)
(9,755,718)
(8,393,675)
Future income tax recovery
–
–
–
–
Net loss after taxes
(7,646,182)
(4,508,199)
(9,755,718)
(8,393,675)
Weighted average number of Common Shares outstanding – basic and diluted
24,889,167
18,139,300
24,345,387
16,825,405
Loss per share – basic and diluted
(0.36)
(0.25)
(0.48)
(0.49)
Summary of Balance Sheet ($CDN)
As at June 30,2020
As at December 31,2019
Assets
$
$
Cash
81,697
441,757
Amounts receivable
1,428,490
1,202,924
Prepaid assets
930,962
704,632
Biological assets
31,285
117,367
Inventory
3,926,691
1,484,371
Right to use asset
441,581
539,710
Property and equipment
20,990,033
22,622,322
Intangible assets
10,686,561
11,063,900
Derivative asset
1,500,574
3,780,000
Investments
72
72
Goodwill
2,520,382
3,207,227
Total Assets
42,538,328
45,164,282
Liabilities and Equity
Amounts payable
6,335,553
5,177,634
Due to related party
2,249,862
3,319,116
Convertible debentures
742,810
715,626
Derivative liability
825
23,434
Lease liability
464,691
555,339
Term loan
–
–
Deferred revenue
3,228,592
3,323,518
Deferred tax liability
2,173,834
2,173,834
Total Liabilities
15,196,167
15,288,501
Shareholder’s equity
27,342,161
29,875,781
Total Liabilities and Shareholder’s Equity
42,538,328
45,164,282
About Avicanna
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.
Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:
Pura H&W: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
RHO Phyto: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.
With ongoing clinical trials on its derma-cosmetic (Pura H&W), medical cannabis (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.
Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.
Stay Connected
For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email at [email protected].
Cautionary Note Regarding Forward-Looking Information and Statements
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Avicanna’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Avicanna’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, the ability of the combined expertise of the Company and CARG to fast-track the development of advanced pharmaceutical formulations of cannabinoids and their route to market, the ability of the Company to certify the safety and stability of the Pura H&W formulations not yet registered with the CPNP, the ability of the Company to sell, export and use CBG seeds for local production in Colombia, the ability of the Company to sell the RHO Phyto products in Canada and internationally, the ability of the Company to manufacture pharmaceutical grade products for clinical trials in Canada, and that the RHO Phyto sublingual spray and topical products will be available through Medical Cannabis by Shoppers in Q3 2020 and that capsules will be available for sale through Medical Cannabis by Shoppers in Q4 2020.
By identifying such information and statements in this manner, Avicanna is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Avicanna to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Avicanna has made certain assumptions.
Among others, the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: decreases in the prevailing prices for cannabis and cannabis products in the markets in which the Company operates; adverse changes in applicable laws; adverse changes in the application or enforcement of current laws, including those related to taxation; increasing costs of compliance with extensive government regulation; changes in general economic, business and political conditions, including changes in the financial markets and in particular in the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; risks related to licensing, including the ability to obtain the requisite licenses or renew existing licenses for the Company’s proposed operations; dependence upon third party service providers, skilled labor and other key inputs; risks inherent in the agricultural and retail business; intellectual property risks; risks related to litigation; dependence upon senior management; and the other risks disclosed in the Company’s annual information form dated April 15, 2020 filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Posted by AGORACOM-JC
at 7:27 AM on Monday, August 17th, 2020
Announced it has been invited to present its contact tracing solutions to the Athletic Directors of the 11 NCAA Division 1 Schools of the Big East Conference (“Big East”), for the purposes of supporting resumption plans that provide a safe environment for students, faculty, athletes, fans and staff
On August 12th, Big East announced the postponement of its fall sports season out of concern for the welfare of student-athletes during the coronavirus pandemic
Moreover, Big East has yet to determine whether winter and spring sports will take place as scheduled and is in search of safety processes and protocols that will provide for the safe resumption of athletic events
VANCOUVER, BC, Aug. 17, 2020 – Loop Insights Inc. (TSXV: MTRX) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive automated marketing, contact tracing, and contactless solutions to the brick and mortar space, is pleased to announce it has been invited to present its contact tracing solutions to the Athletic Directors of the 11 NCAA Division 1 Schools of the Big East Conference (“Big East”), for the purposes of supporting resumption plans that provide a safe environment for students, faculty, athletes, fans and staff.
BIG EAST HAS ESTABLISHED ITSELF AS ONE OF NATION’S EXCEPTIONAL CONFERENCES
The Big East Conference’s member schools include Villanova University, Georgetown University and St. John’s University and represent more than 150,000 students. Big East institutions are located in the nation’s largest media markets, including New York, Chicago, Philadelphia and Washington, D.C.
Since the relaunch of the Big East in 2013, it has sponsored championship competition in ten men’s and twelve women’s NCAA sanctioned sports, producing 12 national champions.
POSTPONEMENT OF BIG EAST FALL SPORTS SEASON UNTIL SAFE PROCESSES AND PROTOCOLS CAN BE ESTABLISHED
On August 12th, Big East announced the postponement of its fall sports season out of concern for the welfare of student-athletes during the coronavirus pandemic. Moreover, Big East has yet to determine whether winter and spring sports will take place as scheduled and is in search of safety processes and protocols that will provide for the safe resumption of athletic events.
Loop Insights CEO Rob Anson stated”It is both an extraordinary honour and a testament to the reputation of our contact tracing technology to be invited to present our solutions to the head Athletic Directors of The Big East Conference. Though our presentation is being made to the Athletic Directors for the purposes of supporting the resumption of athletic events, our solutions will apply to the entirety of the campus, student body, faculty and facilities to expedite physical attendance and related economic activities.”
LOOP CONTACT TRACING SOLUTION PROVIDES NCAA CONFERENCES WITH AN OPPORTUNITY TO RESTART CAMPUS ACTIVITIES AND ECONOMIC RECOVERY
In 2013, Big East forged a landmark, long-term broadcast partnership with FOX Sports in a 12-year, $500 million television contract. FOX’s comprehensive coverage of BIG EAST men’s basketball includes the broadcast of all regular-season games on FOX, FS1, or FS2, as well as the BIG EAST Tournament at Madison Square Garden, college basketball’s longest-running postseason conference tournament.
The postponement of the falls sports season represents a significant loss of important incomes to all members of Big East, who are in need of solutions that not only support a safe environment for fans, staff and athletes, but also optimize their revenue streams that warrant the restart of operations. Loop effectively solves both of these problems with their leading contact tracing solutions providing the comfort necessary to put on events. With fans streaming into these events, Loop’s contactless, artificial intelligence marketing solutions will provide personalized promotions and targeted engagement, leading to higher conversions and transaction revenue at all of our events.
Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia.
Forward-Looking Statements/Information:
This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Posted by AGORACOM-JC
at 5:24 PM on Friday, August 14th, 2020
SPONSOR: Esports Entertainment Group(GMBL:NASDAQ) Millions of people from around the world tune in to watch teams of video game players compete with each other. In first quarter 2020, YouTube reported 1.1 billion hours watched, an increase of 13% when compared to fourth quarter 2019. Wagering on Esports is projected to hit $23 BILLION this year although that number will likely be eclipsed due to the recent pandemic. Esports Entertainment Group is designed for the purpose of facilitating as much of this wagering as possible. LEARN MORE.
The astronomical rise of esports
If this is your first time hearing about esports, you’re behind the curve — esports is one of the fastest growing industries in the world
Last year, the esports industry had an estimated audience of 453 million, up from 293 million in 2016
If you’re bored during quarantine and looking for a fun, popular and lucrative way to pass the time, consider putting down that baking pan or pausing that Netflix show and picking up a controller to join the world of esports, a hot trend in the media and entertainment industry. Esports is a competitive video game sport that has grown to incorporate organized tournaments with professional players. Before the COVID-19 pandemic, these tournaments were almost always in-person events, complete with live audiences and referees who monitored potential cheating.
If this is your first time hearing about esports, you’re behind the curve — esports is one of the fastest growing industries in the world. Last year, the esports industry had an estimated audience of 453 million, up from 293 million in 2016. By 2021, that number is expected to reach 557 million. And it’s not just your stereotypical G Fuel-drinking, Doritos-loving high school guys pushing this growth: Universities across the nation have begun investing in this industry. According to the National Association of Collegiate Esports, more than 170 U.S. colleges have varsity esports programs and are offering around $16 million per year in scholarships. College esports tournaments have attracted over 1,350 schools and 40,000 players.
Even the most traditional Wall Street bankers are taking notice of this industry’s potential to make big money. Most esport viewers are in their teens or early twenties, a much-coveted demographic for advertisers, and 43% of esports fans have an annual household income of $75,000. For brands who want to acquire new, young, high-spending customers, esports is especially attractive. Louis Vuitton, for example, is collaborating with video game developer Riot Games to design virtual items in League of Legends (such as “prestige skins”) that players can buy using real money. The fashion brand also spent 900 hours creating an extravagant custom trophy case that combines Louis Vuitton’s bougie flair with League of Legends’ medieval style. Meanwhile, some companies have profited from esports without even trying. In 2018, professional gamer Ninja crashed the website of MeUndies just by mentioning the underwear brand on a livestream.
Why has esports experienced this meteoric rise in popularity and significance? From a social standpoint, esports is far more inclusive than other sports. Men and women of nearly all ages and from various social groups and demographics can play on the same teams and easy translation in the virtual format tears down the language barrier. Unlike in real sports, where genetics may greatly affect your potential to succeed, in esports, anyone with enough practice can become a competent gamer — and everyone has the potential to compete with the best.
From a technological standpoint, video games with increasingly life-like visuals have enhanced the viewing experience. Games now frequently run on a smooth 60 frames per second with 4K resolution, resulting in extremely realistic animations and an immersive experience. The rise of esports can also be traced to the rise of video games among youth. According to Pew Research, 90% of teens aged 13-17 played video games in 2018. The percentage is 97% among boys of that age. With a high number of youth playing games, it’s not hard to imagine that a few would get interested in esports and start the trend among their peers.
The viewership of esports will only grow, especially as famous names in other industries, such as Jennifer Lopez and Travis Scott, associate themselves with leading esports tournaments. The growth of advertising in esports means that brands will now interface directly with previously hard-to-reach audiences, generating previously unthinkable ways to advertise and making space for unlimited creative potential. So, if you want to curb your bread-making addiction during quarantine and spend this extra time getting ahead of the game (pun absolutely intended), consider esports.
Posted by AGORACOM-JC
at 4:02 PM on Thursday, August 13th, 2020
The dawn of the psychedelics industry could not have come at a more needed time for humanity, as global events have served to exacerbate mental health issues related to anxiety and depression. Investors will need help identifying best of breed psychedelics companies and a review of the Red Light Holland story is all you need to know about where the Company is going.
Red Light Holland (TRIP:CSE) is a psychedelics company focused on the development of premium “magic” truffles in the Netherlands. More than just lip service the Company already has these two very strong pillars in place:
TEAM – In order to help guide the company’s development and operations in the psychedelics space, TRIP has signed former Canopy Growth CEO Bruce Linton as chair of its advisory board and Former Canadian Health Minister, Tony Clement, as Senior Advisor. Company President Hans Derix is a native of the Netherlands and an expert in the space with over a decade of accomplished experience.
BUSINESS – The Company’s recreational brand of magic truffles are expected to be sold in the Netherlands through existing Smart Shops by mid-September, as well as, its e-commerce platform through microdose packs. To this end, TRIP has already commenced growing its first crop of magic truffles months ahead of schedule. The initial batch of approximately 100,000 grams of magic truffles available in late October, 2020.
As if that wasn’t enough, TRIP has also produced a virtual reality experience for prospective customers who want to experience the effects of their products before actually trying it. The AGORACOM thesis of small cap wealth this decade is the convergence of emerging technologies – but even we didn’t foresee the explosive intersection of virtual reality and psychedelics!
If you believe in the future of Psychedelics and Psilocybin in particular, then this interview with Todd Shapiro, CEO of Red Light Holland will be a TRIP.
Posted by AGORACOM-JC
at 3:25 PM on Thursday, August 13th, 2020
SPONSOR: Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality platform that allows businesses to easily launch AR campaigns. Clients Include: NBA Sacramento Kings, Mall of America, AT&T Shape and The Basketball Hall of Fame. The company recently announced partnership with Engaged Nation, an award winning leader in digital engagement marketing for casinos in addition to a collaboration with Music Superstar Flo Rida Learn More.
Future Chelsea stars use augmented reality app to supplement training
Chelsea’s stars of tomorrow are already honing their skills by using the Blues’ groundbreaking new augmented reality mobile phone app.
The Stamford Bridge club’s junior academy players are using the Perfect Play app to supplement their training.
Academy graduate Reece James has provided the first digital masterclass for the tool that is now available for anyone to download.
24 hours have passed since the official launch of Perfect Play and we’re so overwhelmed by the support and amazing comments! There’s so much more to come from Perfect Play! Download today and #TrainWithTheBest
The new app uses video tracking technology to map the user’s space and return inch-perfect data on performance and ability in a host of individual or team challenges.
Chelsea’s academy staff and developers have worked since December 2018 on a product launched this week, one which they believe can take youth training to a whole new digital level.
Chelsea Under-11s head coach Sam Page has helped stars like Mason Mount and Tammy Abraham through the Stamford Bridge ranks and has taken a lead role on the new app.
“We’ve actually already used the app with our academy players and it’s been a really interesting part of our home learning programmes that we developed during the course of the pandemic lockdown,” Page told the PA news agency.
“It presented a really exciting opportunity for us with Perfect Play, and we offered the testing version of the app to our academy players from the Under-Nines to Under-13s as part of their home learning programme.
“They tested it for us and had it as part of their programme, so we had some really nice feedback and were able to make some refinements off the back of that.
“And moving forward we’re really keen for it to be a supplementary part of the programme for the youngest age groups that we only see on a part-time basis.
“Our goal is to remain at the forefront of what’s happening in global academy football, we always aspire to be world-leading.
It’s been fantastic working on this project for the past 18months. I am now really excited to see where we go next. https://t.co/o0h7pswPpy
“Our head of youth development Neil Bath really drives us as coaches to think in a fully-integrated fashion, and about all the technologies that come with that.
“Perfect Play is a really good example of how as coaches we can think about what technology can do to enhance our coaching practice.”
Manager Frank Lampard awarded a record number of senior debuts to home-grown stars in his first season at the Stamford Bridge helm.
Page admitted his own pride at seeing such a bumper crop of academy graduates, especially when witnessing England midfielder Mount hit the net in the 1-1 home draw with Leicester at the start of the campaign.
“There is immense pride in seeing a lot of our lads playing at Stamford Bridge,” said Page.
“For me the memory of Mason scoring against Leicester in the first game, I’ve been to many games at Stamford Bridge but that’s a very special memory for me.
“We talk to our players about it now, about the pathway and the expectations that Frank has, and the things he talks to us as academy staff about; the commitment, hard work, dedication, all of those core fundamental skills that we’ve also tried to embed in the Perfect Play app.” Stars like Mason Mount, pictured, were helped through Chelsea’s academy by Sam Page, one of the key contributors to the club’s new training app (Alastair Grant/NMC Pool)
Product owner Steve Didd will continue to work with Chelsea on refining an app he believes can help radically alter general sports training.
“Technology is going to be hugely influential in terms of how people train, and it’s something we’re hugely excited about delivering within Perfect Play,” Didd told the PA news agency.
“Our goal with the product is to make kids better footballers, and this technology enables us to show them they are getting better, because it captures their performances.
“Kids are very tech savvy now, but this should be extremely intuitive to set up and use and we believe it’s going to become an essential part of football training moving forwards.
“We’re taking elite academy methodologies that have been developed over decades, digitising that, and allowing kids to have that same kind of training, that wouldn’t be accessible elsewhere. So it’s there to help kids improve and gain the edge.
“We already have a masterclass in the app with Reece James.
“We’re heavily involved with the first-team men and women as well as the academy kids who feature. And we’ll be doing more masterclasses with players from both the men’s and women’s team.”
Posted by AGORACOM-JC
at 10:07 AM on Thursday, August 13th, 2020
Entered into an additional sales agreement for approximately $2.3M with Lotte Home Shopping Co. Ltd., bringing the total gross sales to $3.3M this year so far
LOTTE Home Shopping operates large retail stores and department stores in various countries like Japan, South Korea, China, and Vietnam
Datametrex is continuously working with the various divisions of LOTTE as a preferred vendor
LOTTE Group is the fifth-largest conglomerate in Korea with annual revenues of approximately USD 60 billion, consisting of over 90 business divisions.
TORONTO, Aug. 13, 2020 — Datametrex AI Limited(the “Company” or “Datametrex“) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce that it has entered into an additional sales agreement for approximately $2.3M with Lotte Home Shopping Co. Ltd. (“LOTTE”), bringing the total gross sales to $3.3M this year so far.
LOTTE Home Shopping operates large retail stores and department stores in various countries like Japan, South Korea, China, and Vietnam.
Datametrex is continuously working with the various divisions of LOTTE as a preferred vendor. Datametrex has demonstrated to be a quality, reliable, and trustworthy partner, with an opportunity to grow within the 934 companies in the LOTTE family.
“At Datametrex, we continue our efforts to facilitate ground-breaking technologies to companies across the globe. We pride ourselves in providing tools that our clients can use to visualize their customer and stakeholder data in order to make predictive analyses, mitigate risk, and improve their bottom line,” stated Marshall Gunter, CEO of Datametrex.
Datametrex plans to deliver the contract in August with full payment in September 2020.
Datametrex is also pleased to share that the Company has won a tender from LOTTE Property and Development Co. Ltd. for approximately $100K.
About LOTTE Group
LOTTE Group is the fifth-largest conglomerate in Korea with annual revenues of approximately USD 60 billion, consisting of over 90 business divisions. LOTTE is engaged in diverse industries that include hotels, resorts, fast food, beverages, retail, financial services, heavy chemicals, electronics, IT, construction, publishing, confectionary products, and entertainment. Additional information on LOTTE is available at www.lotte.co.kr
About Datametrex
Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com
For further information, please contact:
Marshall Gunter – CEO Phone: (514) 295-2300 Email: [email protected]
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 9:16 AM on Thursday, August 13th, 2020
Updated Earnings Guidance for Q3 2020 and full year 2020:
Management continues to expect significant revenue growth
Q3 2020 updated EPS> $0.07
Full year 2020 updated EPS > $0.11.
MONTREAL, Aug. 13, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, is pleased to provide today, further to its Q2 2020 financial press release dated July 29th, 2020, updated earnings per share (“EPS”) guidance for Q3 2020, and the full year 2020.
PyroGenesis now expects EPS for Q3 2020 to be in excess of $0.07. On July 29th, 2020, the Company had given prior guidance of $0.06 for the same period. Furthermore, the Company now expects an EPS for the full year 2020 to be conservatively in excess of $0.11.
“We understand the market’s interest in our providing guidance, so we are progressing cautiously and conservatively as we are committed to meet or exceed market expectations,” said P. Peter Pascali, CEO and President of PyroGenesis. “Our confidence, and increased visibility, in our Q3 2020 results has resulted in this update, and we will continue to provide such updates as needed. The Company continues to exceed internal expectations in the execution of all its projects and business lines with little to no impact from the summer holiday period nor the ongoing pandemic.”
Updated Earnings Guidance for Q3 2020 and full year 2020:
Management continues to expect significant revenue growth
Q3 2020 updated EPS> $0.07
Full year 2020 updated EPS > $0.11.
About PyroGenesis Canada Inc. PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.
This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws.
Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.
SOURCE PyroGenesis Canada Inc.
For further information please contact: Rodayna Kafal, Vice President Investors Relations and Strategic Business Development Phone: (514) 937-0002, E-mail: [email protected] RELATED LINK: https://www.pyrogenesis.com/
Posted by AGORACOM-JC
at 7:14 AM on Thursday, August 13th, 2020
Scheduled to participate in a virtual presentation and fireside chat at the August 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, August 19, 2020 at 10:00am ET (7:00am PT).
VANCOUVER, BC August 13, 2020 /ELSE NUTRITION HOLDINGS INC.(TSXV:BABY)(OTCQX:BABYF)(FSE:0YL) (“Else” or the “Company“), a developer of plant-based alternatives to dairy-based baby nutrition, is scheduled to participate in a virtual presentation and fireside chat at the August 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, August 19, 2020 at 10:00am ET (7:00am PT).
Management will also be participating in virtual one-on-one meetings on August 19-20, 2020. To arrange a meeting, please contact Ben Shamsian of Lytham Partners at [email protected] or visit www.lythampartners.com/virtual.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan. The holding company, Else Nutrition Holdings Inc, is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children’s Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.
For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.
For more information, contact:
Ms. Hamutal Yitzhak, CEO, Co-Founder & Director ELSE Nutrition Holdings Inc. E: [email protected] P: +972(0)3-6445095
Mr. Sokhie Puar, Director of Else Nutrition Email: [email protected] Telephone: 604-603-7787
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will”, “expect” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that listing on the FSE will create additional liquidity and attract additional investors in the European market. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
View original content to download multimedia: 
/cloudfront-us-east-1.images.arcpublishing.com/shropshirestar.mna/JDDCRC34RZGQHCBPMJRB2BEMPY.jpg)
Stars like Mason Mount, pictured, were helped through Chelsea’s academy by Sam Page, one of the key contributors to the club’s new training app (Alastair Grant/NMC Pool)
